ertiprotafib has been researched along with rk 682 in 1 studies
| Studies (ertiprotafib) | Trials (ertiprotafib) | Recent Studies (post-2010) (ertiprotafib) | Studies (rk 682) | Trials (rk 682) | Recent Studies (post-2010) (rk 682) |
|---|---|---|---|---|---|
| 16 | 1 | 8 | 23 | 0 | 9 |
| Protein | Taxonomy | ertiprotafib (IC50) | rk 682 (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 4.6 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 4.6 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 5.1 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 4.4357 | |
| M-phase inducer phosphatase 2 | Mus musculus (house mouse) | 3.65 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 4.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buirchell, B; Møller, BL; Ndi, C; Pedersen, HA; Semple, SJ; Staerk, D | 1 |
1 other study(ies) available for ertiprotafib and rk 682
| Article | Year |
|---|---|
PTP1B-Inhibiting Branched-Chain Fatty Acid Dimers from
Topics: alpha-Glucosidases; Chromatography, High Pressure Liquid; Fatty Acids; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Scrophulariaceae; Solid Phase Extraction | 2020 |